Top

Malaria Journal

Published in:

Open Access 01-12-2015 | Research

Predicting the impact of border control on malaria transmission: a simulated focal screen and treat campaign

Authors: Sheetal P Silal, Francesca Little, Karen I Barnes, Lisa J White

Published in: Malaria Journal | Issue 1/2015

Abstract

Background

South Africa is one of many countries committed to malaria elimination with a target of 2018 and all malaria-endemic provinces, including Mpumalanga, are increasing efforts towards this ambitious goal. The reduction of imported infections is a vital element of an elimination strategy, particularly if a country is already experiencing high levels of imported infections. Border control of malaria is one tool that may be considered.

Methods

A metapopulation, non-linear stochastic ordinary differential equation model is used to simulate malaria transmission in Mpumalanga and Maputo province, Mozambique (the source of the majority of imported infections) to predict the impact of a focal screen and treat campaign at the Mpumalanga–Maputo border. This campaign is simulated by nesting an individual-based model for the focal screen and treat campaign within the metapopulation transmission model.

Results

The model predicts that such a campaign, simulated for different levels of resources, coverage and take-up rates with a variety of screening tools, will not eliminate malaria on its own, but will reduce transmission substantially. Making the campaign mandatory decreases transmission further though sub-patent infections are likely to remain undetected if the diagnostic tool is not adequately sensitive. Replacing screening and treating with mass drug administration results in substantially larger decreases as all (including sub-patent) infections are treated before movement into Mpumalanga.

Conclusions

The reduction of imported cases will be vital to any future malaria control or elimination strategy. This simulation predicts that FSAT at the Mpumalanga–Maputo border will be unable to eliminate local malaria on its own, but may still play a key role in detecting and treating imported infections before they enter the country. Thus FSAT may form part of an integrated elimination strategy where a variety of interventions are employed together to achieve malaria elimination.

Available only for authorised users

The malERA Consultative Group on Basic Science and Enabling (2011) A research agenda for malaria eradication: basic science and enabling technologies. PloS Med 8(1). Available from: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000399

The malERA Consultative Group on Diagnoses (2011) A research agenda for malaria eradication: diagnoses and diagnostics. PloS Med 8(1). Available from: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000396

The malERA Consultative Group on Drugs (2011) A research agenda for malaria eradication: drugs. PloS Med 8(1). Available from: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000402

The malERA Consultative Group on Modeling (2011) A research agenda for malaria eradication: modeling. PloS Med 8(1). Available from: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000403

The malERA Consultative Group on Vector Control (2011) A research agenda for malaria eradication: vector control. PloS Med 8(1). Available from: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000401

Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL et al (2010) Operational strategies to achieve and maintain malaria elimination. Lancet 376(9752):1592–603. Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61269-X/fulltext

(2007) Malaria elimination. A field manual for low and moderate endemic countries. World Health Organisation, Geneva. Available from: http://www.who.int/malaria/publications/atoz/9789241596084/en/

Silal SP, Little F, Barnes KI, White LJ (2014) Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modeling approach. Malar J 3(297). Available from: http://www.malariajournal.com/content/pdf/1475-2875-13-297.pdf

Silal SP, Little F, Barnes KI, White LJ (2015) Hitting a moving target: a model for malaria elimination in the presence of population movement. PLoS One (Under Review)

10.

Silal SP, Barnes KI, Kok G, Mabuza A, Little F (2013) Exploring the seasonality of reported treated malaria cases in Mpumalanga, South Africa. PLoS One 8(10):e76640. Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076640

11.

Maharaj R, Raman J, Morris N, Moonasar D, Durrheim DN, Seocharan I et al (2013) Epidemiology of malaria in South Africa: From control to elimination. S Afr Med J 103(10):779–783. Available from: http://www.samj.org.za/index.php/samj/article/view/7441/5461

12.

Moonasar D, Nuthulaganti T, Kruger PS, Mabuza A, Rasiswi ES, Benson FG et al (2012) Malaria control in South Africa 2000–2010: beyond MDG6. Malar J 11(1):294. Available from: http://www.malariajournal.com/content/11/1/294

13.

Ngomane L, de Jager C (2012) Changes in malaria morbidity and mortality in Mpumalanga Province, South Africa (2001–2009): a retrospective study. Malar J 11(1):19. Available from: http://www.malariajournal.com/content/11/1/19

14.

Govere J, Durrheim D, Coetzee M, Hunt RH (2001) Malaria in Mpumalanga, South Africa, with special reference to the period 1987–1999. S Afr J Sci 97:55–58

15.

Sharp BL, le Sueur D (1996) Malaria in South Africa-the past, the present and selected implications for the future. S Afr Med J 86(1):83–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8685790

16.

Sharp B, Craig MH, Mnzava A, Curtis B, Maharaj R, Kleinschmidt I (2001) Review of malaria in South Africa. Health Systems Trust, Westville

17.

Blumberg L, Frean J (2007) Malaria control in South Africa—and successes, vol 97. http://www.samj.org.za/index.php/samj/article/view/304. S Afr Med J (11):1193

18.

Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN et al (2007) Seven years of regional malaria control collaboration—Mozambique, South Africa and Swaziland. Am J Trop Med Hyg. 76(1):42–47PubMedCentralPubMed

19.

Lubombo Spatial Development Initiative; 2014 [cited 05/03/14]. Available from: http://www.malaria.org.za/lsdi/home.html

20.

President’s Malaria Initiative (2013) Mozambique Malaria Operational Plan Financial Year: 2013. President’s Malaria Initiative

21.

Mandal S, Sarkar RR, Sinha S (2011) Mathematical models of malaria-a review. Malar J 10(1):202. Available from: http://www.malariajournal.com/content/10/1/202

22.

Vittorini P, di Orio F (2013). In: Mohamad MS, Nanni L, Rocha MP, Fdez-Riverola F (eds) 7th international conference on practical applications of computational biology and bioinformatics. Vol. 222 of advances in intelligent systems and computing. Heidelberg: Springer International Publishing. Available from: http://link.springer.com/10.1007/978-3-319-00578-2

23.

Sattenspiel L, Lloyd A (2009) The geographic spread of infectious diseases: models and applications. Princeton University Press, Princeton. Available from: http://books.google.com/books?id=jtGP_qwD1MgC&pgis=1

24.

Ariey F, Duchemin JB, Robert V (2003) Metapopulation concepts applied to falciparum malaria and their impacts on the emergence and spread of chloroquine resistance. Infect Genet Evol 2(3):185–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12797980

25.

Oluwagbemi OO, Fornadel CM, Adebiyi EF, Norris DE, Rasgon JL (2013) ANOSPEX: a stochastic, spatially explicit model for studying Anopheles metapopulation dynamics. PLoS One 8(7). Available from: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0068040#pone-0068040-g004

26.

Le Menach A, McKenzie FE, Flahault A, Smith DL (2005) The unexpected importance of mosquito oviposition behaviour for malaria: non-productive larval habitats can be sources for malaria transmission. Malar J 4(1):23. Available from: http://www.malariajournal.com/content/4/1/23

27.

Smith DL, Dushoff J, McKenzie FE (2004) The risk of a mosquito-borne infection in a heterogeneous environment. PLoS Biol 2(11). Available from: http://dx.plos.org/10.1371/journal.pbio.0020368

28.

Arino J, Ducrot A, Zongo P (2012) A metapopulation model for malaria with transmission-blocking partial immunity in hosts. J Math Biol 64(3):423–448. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21442182

29.

Zorom M, Zongo P, Barbier B, Somé B (2012) Optimal control of a spatio-temporal model for Malaria: synergy treatment and prevention. J Appl Math

30.

Auger P, Kouokam E, Sallet G, Tchuente M, Tsanou B (2008) The Ross–Macdonald model in a patchy environment. Math Biosci 216(2):123–131. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18805432

31.

Rodriguez DJ, Torres-Sorando L (2001) Models of infectious diseases in spatially heterogeneous environments. Bull Math Biol 63(3):547–571. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11374305

32.

Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White MJ et al (2011) The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One 6(5). Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0020179

33.

Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W et al (2010) Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PloS Med 7(8). Available from: http://www.ncbi.nlm.nih.gov/pubmed/20711482

34.

Smith T, Maire N, Ross a, Penny M, Chitnis N, Schapira A et al (2008) Towards a comprehensive simulation model of malaria epidemiology and control. Parasitol 135(13):1507–1516. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18694530

35.

Maire N, Smith T, Ross A, Owusu-Agyei S, Dietz K, Molineaux L (2006) A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg 75(2):19–31. Available from: http://www.ajtmh.org/content/75/2_suppl/19.abstract

36.

Crowell V, Briët OJT, Hardy D, Chitnis N, Maire N, Di Pasquale A et al (2013) Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden. Malar J 12(1):4. Available from: http://www.malariajournal.com/content/12/1/4

37.

Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM et al (2009) The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J 8. Available from: http://www.malariajournal.com/content/8/1/31

38.

White LJ, Maude RJ, Pongtavornpinyo W, Saralamba S, Aguas R, Van Effelterre T et al (2009) The role of simple mathematical models in malaria elimination strategy design. Malar J 8:212. Available from: http://www.malariajournal.com/content/8/1/212

39.

Craig MH, Snow RW, le Sueur D (1999) A climate-based distribution model of malaria transmission in Sub-Saharan Africa. Parasitol Today 15(3):105–111. doi:10.1016/S0169-4758(99)01396-4

40.

Montosi E, Manzoni S, Porporato A, Montanari A (2012) An ecohydrological model of malaria outbreaks. Hydrol Earth Syst Sci. Aug, 16(8):2759–2769. Available from: http://www.hydrol-earth-syst-sci.net/16/2759/2012/hess-16-2759-2012.html

41.

Coleman M, Coleman M, Mabuza AM, Kok G, Coetzee M, Durrheim DN (2009) Using the SaTScan method to detect local malaria clusters for guiding malaria control programmes. Malar J 8(1):68. Available from: http://www.malariajournal.com/content/8/1/68

42.

Koella JC, Antia R (2003) Epidemiological models for the spread of anti-malarial resistance. Malar J 2(3). Available from: http://www.malariajournal.com/content/2/1/3

43.

Cleveland RB (1990) STL: a seasonal-trend decomposition procedure based on LOESS. J Off Stat 6(1). Available from: http://cs.wellesley.edu/cs315/Papers/stl%20statistical%20model.pdf

44.

Kennedy J, Eberhart R Particle swarm optimization. In: Proceedings of ICNN’95—international conference on neural networks. vol 4. IEEE, pp 1942–1948. Available from: http://ieeexplore.ieee.org/articleDetails.jsp?arnumber=488968

45.

Eberhart R, Kennedy J (1995) A new optimizer using particle swarm theory. In: MHS’95. Proceedings of the sixth international symposium on micro machine and human science. IEEE, pp 39–43. Available from: http://ieeexplore.ieee.org/articleDetails.jsp?arnumber=494215

46.

R Core Group (2013) [cited 2013–12-20]. Available from: http://www.r-project.org

47.

Zambrano-Bigiarini M, Rojas R (2013) A model-independent Particle Swarm Optimisation software for model calibration. Environ Model Softw 43:5–25. doi: 10.1016/j.envsoft.2013.01.004

48.

Zambrano-Bigiarini M, Rojas R (2013) hydroPSO: Particle Swarm Optimisation, with focus on environmental models. R package version 0.3-3—for new features, see the ’NEWS’ file (on CRAN, rforge or the package source). Available from: http://www.rforge.net/hydroPSO, http://cran.r-project.org/web/packages/hydroPSO

49.

Grueninger H, Hamed K (2013) Transitioning from malaria control to elimination: the vital role of ACTs. Trends Parasitol 29(2):60–4. Available from:

50.

DHA Media Release (2005) South Africa and Mozambique sign a Visa Waiver Agreement. Department of Home Affairs, Pretoria, South Africa

51.

Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E et al (2005) Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PloS Med 2(11):e330PubMedCentralPubMedCrossRef

52.

von Seidlein L The failure of screening and treating as a malaria elimination strategy. PloS Med. (1). Available from: http://dx.plos.org/10.1371/journal.pmed.1001595

53.

Halliday KE, Okello G, Turner EL, Njagi K, Mcharo C, Kengo J et al (2014) Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial. PloS Med 11(1):e1001594. Available from: http://dx.plos.org/10.1371/journal.pmed.1001594

54.

Okell LC, Bousema T, Griffin JT, Ouédraogo AL, Ghani AC, Drakeley CJ (2012) Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 3:1237. doi:10.1038/ncomms2241

55.

Mosha JF, Sturrock HJW, Greenhouse B, Greenwood B, Sutherland CJ, Gadalla N et al (2013) Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar J 12(1):221. Available from: http://www.malariajournal.com/content/12/1/221

56.

(2011) National Malaria Elimination Strategy 2011–2018. South African National Department of Health, Pretoria

57.

Toovey S, Jamieson A, Holloway M (2004) Travelers’ knowledge, attitudes and practices on the prevention of infectious diseases: results from a study at Johannesburg International Airport. J Travel Med 11(1):16–22PubMedCrossRef

58.

(2012) Census 2011 Municipal report Mpumalanga. Statistics South Africa. Available from: http://www.statssa.gov.za/Census2011/Products/MP_Municipal_Report.pdf

59.

Zacarias OP, Andersson M et al (2010) Mapping malaria incidence distribution that accounts for environmental factors in Maputo Province-Mozambique. Malar J. 9:79PubMedCentralPubMedCrossRef

60.

(2013) Mortality and causes of death in South Africa, 2010: Findings from death notification. Pretoria: Statistics South Africa. Available from: http://www.statssa.gov.za/publications/p03093/p030932010.pdf

61.

Thomson D (1911) A research into the production, life and death of crescents in malignant tertian malaria, in treated and untreated cases, by an enumerative method; the leucocytes in malarial fever: a method of diagnosing malaria long after it is apparently cured. University Press

62.

Eyles DE, Young MD (1951) The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host. J Natl Malar Soc 10(4):327–336. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14908561

63.

Collins WE, Jeffery GM (1999) A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection. Am J Trop Med Hyg 61(1 Suppl):4–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10432041

64.

Chitnis N, Hyman JM, Cushing JM (2008) Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model. Bull Math Biol 70(5):1272–1296. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18293044

65.

Makanga M, Krudsood S (2009) The clinical efficacy of artemether/lumefantrine (Coartem). Malar J 8(Suppl 1). Available from: http://www.malariajournal.com/content/8/S1/S5

66.

Castillo-Riquelme M, McIntyre D, Barnes K (2008) Household burden of malaria in South Africa and Mozambique: is there a catastrophic impact? Trop Med Int Health 13(1):108–122. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18291009

67.

Hlongwana KW, Zitha A, Mabuza AM, Maharaj R (2011) Knowledge and practices towards malaria amongst residents of Bushbuckridge, Mpumalanga, South Africa. Afr J Prim Health Care Fam Med 3(1). Available from: http://www.phcfm.org/index.php/phcfm/article/view/257

68.

Sama W, Owusu-Agyei S, Felger I, Dietz K, Smith T (2006) Age and seasonal variation in the transition rates and detectability of Plasmodium falciparum malaria. Parasitol 132(Pt 1):13–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16393349

69.

Filipe JAN, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC (2007) Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol 3(12):e255. Available from: http://dx.plos.org/10.1371/journal.pcbi.0030255

70.

Griffin JT, Ferguson NM, Ghani AC (2014) Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun 5. Available from: http://www.nature.com/ncomms/2014/140211/ncomms4136/pdf/ncomms4136.pdf

71.

Zaloumis S, Humberstone A, Charman SA, Price RN, Moehrle J, Gamo-Benito J et al (2012) Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development. Malar J 11(1). Available from: http://www.malariajournal.com/content/11/1/303

72.

Hendriksen ICE, White LJ, Veenemans J, Mtove G, Woodrow C, Amos B et al (2013) Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis 207(2):351–361. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23136222

73.

Starzengruber P, Fuehrer HP, Ley B, Thriemer K, Swoboda P, Habler VE et al (2013) High prevalence of asymptomatic malaria in south-eastern Bangladesh. Malar J 13:16. Available from: http://www.malariajournal.com/content/13/1/16

74.

Hopkins H, Gonzalez IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C et al (2013) Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis 208(4):645–652. Available from: http://jid.oxfordjournals.org/content/early/2013/05/31/infdis.jit184.full

75.

Polley SD, Gonzalez IJ, Mohamed D, Daly R, Bowers K, Watson J et al (2013) Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J Infect Dis 208(4):637–644. Available from: http://jid.oxfordjournals.org/content/early/2013/04/30/infdis.jit183.abstract?keytype=ref

Title: Predicting the impact of border control on malaria transmission: a simulated focal screen and treat campaign
Authors: Sheetal P Silal
Francesca Little
Karen I Barnes
Lisa J White
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Malaria Journal / Issue 1/2015
Electronic ISSN: 1475-2875
DOI: https://doi.org/10.1186/s12936-015-0776-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Genetic evidence for contribution of human dispersal to the genetic diversity of EBA-175 in Plasmodium falciparum

Implementation of the global plan for insecticide resistance management in malaria vectors: progress, challenges and the way forward

The hyper-reactive malarial splenomegaly: a systematic review of the literature

Paradoxical sleep deprivation impairs mouse survival after infection with malaria parasites

Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya

Is there malaria transmission in urban settings in Colombia?

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage